Search Results - "метастатический рак предстательной железы"

1

Academic Journal

Whole body magnetic resonance imaging (WB MRI) in the diagnosis and evaluation of the effectiveness of treatment of metastatic prostate cancer: Met-RADS-P system standards ; Магнитно-резонансная томография всего тела в диагностике и оценке эффективности лечения метастатического рака предстательной железы: стандарты системы Met-RADS-P

Authors: T. P. Berezovskaya, V. O. Ripp, A. V. Troyanov, S. A. Ivanov, A. D. Kaprin, Т. П. Березовская, В. О. Рипп, А. В. Троянов, С. А. Иванов, А. Д. Каприн

Source: Diagnostic radiology and radiotherapy; Том 15, № 3 (2024); 19-31 ; Лучевая диагностика и терапия; Том 15, № 3 (2024); 19-31 ; 2079-5343

Subject Terms: Met-RADS-P, diffusion-weighted whole-body imaging, metastatic prostate cancer, диффузионно-взвешенная томография всего тела, метастатический рак предстательной железы

File Description: application/pdf

Relation: https://radiag.bmoc-spb.ru/jour/article/view/1018/654; Padhani A.R., Liu G., Koh D.M. et al. Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations // Neoplasia. 2009. Vol. 11, No. 2. Р. 102–125. doi:10.1593/neo.81328.; Summers P. Saia G., Colombo A. et al. Whole-body magnetic resonance imaging: technique, guidelines and key applications // Ecancer medical science. 2021. Vol. 15. Р. 1164. doi:10.3332/ecancer.2021.1164.; Messiou C., Hillengass J., Delorme S. et al. Guidelines for acquisition, interpretation, and reporting of whole-body MRI in myeloma: myeloma response assessment and diagnosis system (MY-RADS) // Radiology. 2019. Vol. 291. Р. 5–13. doi:10.1148/radiol.2019181949.; Petralia G., Koh D.M., Attariwala R. et al. Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for the Acquisition, Interpretation, and Reporting of Whole-Body MRI for Cancer Screening // Radiology. 2021. Vol. 299, No. 3. Р. 494–507. doi:10.1148/radiol.2021201740.; Padhani A.R., Lecouvet F.E., Tunariu N. et al. METastasis Reporting and Data System for Prostate Cancer: Practical Guidelines for Acquisition, Interpretation, and Reporting of Whole-body Magnetic Resonance Imaging-based Evaluations of Multiorgan Involvement in Advanced Prostate Cancer // Eur. Urol. 2017. Vol. 71, No. 1. Р. 81–92. doi:10.1016/j.eururo.2016.05.033.; Schmidt G.P., Schoenberg S.O., Reiser M.F. et al. Whole-body MR imaging of bone marrow // Eur. J. Radiol. 2005. Vol. 55. Р. 33–40. doi:10.1016/j.ejrad.2005.01.019.; Dixon WT. Simple proton spectroscopic imaging // Radiology. 1984. Vol. 153, No. 1. Р. 189–194. doi:10.1148/radiology.153.1.6089263.; Bray T.J., Chouhan M.D., Punwani S., Bainbridge A., Hall-Craggs M.A. Fat fraction mapping using magnetic resonance imaging: insight into pathophysiology // Br. J. Radiol. 2018 Sep. Vol. 91, No. 1089. Р. 20170344. doi:10.1259/bjr.20170344.; Gee C.S., Nguyen J.T., Marquez C.J., Heunis J., Lai A., Wyatt C., Han M., Kazakia G., Burghardt A.J., Karampinos D.C., Carballido-Gamio J., Krug R. Validation of bone marrow fat quantification in the presence of trabecular bone using MRI // J. Magn. Reson. Imaging. 2015. Vol. 42, No. 2. Р. 539–544. doi:10.1002/jmri.24795.; Guerini H., Omoumi P., Guichoux F. et al. Fat suppression with Dixon techniques in musculoskeletal magnetic resonance imaging: a pictorial review // Semin Musculoskeletal Radiol. 2015. Vol. 19. Р. 335–347.; Lins C.F., Salmon C.E.G., Nogueira-Barbosa M.H. Applications of the Dixon technique in the evaluation of the musculoskeletal system // Radiol. Bras. 2021. Vol. 54, No. 1. Р. 33–42. doi:10.1590/0100-3984.2019.0086.; Lecouvet F.E., Pasoglou V., Van Nieuwenhove S., Van Haver T., de Broqueville Q., Denolin V. et al. Shortening the acquisition time of whole-body MRI: 3D T1 gradient echo Dixon vs fast spin echo for metastatic screening in prostate cancer // Eur. Radiol. 2020. Vol. 30, No. 6. Р. 3083–3093.; Михайлов А.И., Панов В.О., Мещерякова Н.А., Пронин А.И., Вихрова Н.Б., Долгушин М.Б. Диффузионно-взвешенная магнитно-резонансная томография всего тела с оценкой измеряемого коэффициента диффузии при лимфоме Ходжкина // Онкологический журнал: лучевая диагностика, лучевая терапия. 2018. Vol. 1, № 3. С. 44–48. doi:10.37174/2587-7593-2018-1-3-44-48; Kwee T.C., Takahara T., Ochiai R., Nievelstein R.A., Luijten P.R. Diffusion-weighted whole-body imaging with background body signal suppression (DWIBS): features and potential applications in oncology // Eur. Radiol. 2008. Vol. 18, No. 9. Р. 1937–1952. doi:10.1007/s00330-008-0968-z.; Takahara et al. Diffusion weighted whole body imaging with background body signal suppression (DWIBS): Technical improvement using free breathing, STIR and high resolution 3D display // Radiation medicine. 2003. Vol. 22. Р. 275–282.; Nagarajan R., Margolis D., Raman S., Sheng К., King Ch., Reiter R., Thomas M.A. Correlation of Gleason Scores with Diffusion-Weighted Imaging Findings of Prostate Cancer // Advances in Urology. 2012. Vol. 2012, 5 p. https://doi.org/10.1155/2012/374805.; Manetta R., Palumbo P., Gianneramo C. et al. Correlation between ADC values and Gleason score in evaluation of prostate cancer: multicentre experience and review of the literature // Gland Surg. 2019. Vol. 8, Suppl. 3. Р. S216-S222. doi:10.21037/gs.2019.05.02.; Shi Y.J., Li X.T., Zhang X.Y., Liu Y.L., Tang L., Sun Y.S. Differential diagnosis of hemangiomas from spinal osteolytic metastases using 3.0 T MRI: comparison of T1-weighted imaging, chemical-shift imaging, diffusion-weighted and contrast-enhanced imaging // Oncotarget. 2017. Vol. 8, No. 41. Р. 71095–71104. doi:10.18632/oncotarget.20533.; Koh D.M., Blackledge M., Padhani A.R. et al. Whole-body diffusion-weighted MRI: tips, tricks, and pitfalls // AJR Am. J. Roentgenol. 2012. Vol. 199, No. 2. Р. 252– 262. doi:10.2214/AJR.11.7866.; Van Nieuwenhove S., Van Damme J., Padhani A.R., Vandecaveye V., Tombal B., Wuts J., Pasoglou V., Lecouvet F.E. Whole-body magnetic resonance imaging for prostate cancer assessment: Current status and future directions // J. Magn. Reson. Imaging. 2022. 55: 653–80. https://doi.org/10.1002/jmri.27485.; Grimm A., Meyer H., Nickel M.D. et al. Evaluation of 2-point, 3-point, and 6-point Dixon magnetic resonance imaging with flexible echo timing for muscle fat quantification // Eur. J. Radiol. 2018. Vol. 103. Р. 57–64.; Gandaglia G., Abdollah F., Schiffmann J., Trudeau V., Shariat SF., Kim SP., Perrotte P., Montorsi F., Briganti A., Trinh QD., Karakiewicz PI., Sun M. Distribution of metastatic sites in patients with prostate cancer: A population-based analysis // Prostate. 2014. Feb. Vol. 74, No. 2. Р. 210–216. doi:10.1002/pros.22742.; Scher H.I., Morris M.J., Stadler W.M. et al. Trial Design and Objectives for Castration-Resistant Prostate Cancer: Updated Recommendations From the Prostate Cancer Clinical Trials Working Group 3 // J. Clin. Oncol. 2016. Vol. 34, No. 12. Р. 1402–1418. doi:10.1200/JCO.2015.64.2702.; Lapini A., Caffo O., Pappagallo G., Iacovelli R., D’Angelillo R.M., Vavassori V., Ceccarelli R., Bracarda S., Jereczek-Fossa B.A., Da Pozzo L., Conti G.N. Monitoring Patients with Metastatic Hormone-Sensitive and Metastatic Castration-Resistant Prostate Cancer: A Multidisciplinary Consensus Document // Cancers (Basel). 2019 Dec 1. Vol. 11, No. 12. Р. 1908. doi:10.3390/cancers11121908.; Eisenhauer E.A., Therasse P., Bogaerts J. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1) // Eur. J. Cancer. 2009. Vol. 45. Р. 228–247.; Pricolo P., Ancona E., Summers P. et al. Whole-body magnetic resonance imaging (WB-MRI) reporting with the METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P): inter-observer agreement between readers of different expertise levels // Cancer Imaging. 2020. Vol. 20, No. 1. Р. 77. doi:10.1186/s40644-020-00350-x.; Liu X., Xie T., Sun Z., Guo Y., Zhang X., Wang X. Analysis of interreader agreement in structured reports of pelvic multiparametric magnetic resonance imaging using the METastasis Reporting and Data System for Prostate Cancer guidelines // Diagn. Interv. Radiol. 2023. Jan 31. Vol. 29, No. 1. Р. 29–39. doi:10.5152/dir.2022.211232.; Yoshida S., Takahara T., Ishii C. et al. METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer // Clin. Genitourin Cancer. 2020. Vol. 18, No. 4. Р. e391-e396. doi:10.1016/j.clgc.2019.12.010.

Availability: https://radiag.bmoc-spb.ru/jour/article/view/1018
https://doi.org/10.22328/2079-5343-2024-15-3-19-31

View record from BASE

2

Academic Journal

Primary multiple synchronous tumors: soft tissue sarcoma of the retroperitoneal space and metastatic prostate cancer ; Первично-множественные синхронные опухоли: саркома мягких тканей забрюшинного пространства и метастатический рак предстательной железы

Authors: O. A. Mailyan, K. Yu. Kanukoev, P. G. Berezin, K. M. Nyushko, V. A. Gorbach, О. А. Маилян, К. Ю. Канукоев, П. Г. Березин, К. М. Нюшко, В. А. Горбач

Source: Research and Practical Medicine Journal; Том 7, № 2 (2020); 171-178 ; Research'n Practical Medicine Journal; Том 7, № 2 (2020); 171-178 ; 2410-1893 ; 10.17709/2409-2231-2020-7-2

Subject Terms: комбинированное лечение, metastatic prostate cancer, soft tissue sarcoma of the retroperitoneal space, dedifferentiated retroperitoneal liposarcoma, nephroadrenalectomy, combination treatment, метастатический рак предстательной железы, саркома мягких тканей забрюшинного пространства, дедиференцированная липосаркома забрюшинного пространства, нефроадреналэктомия

File Description: application/pdf

Relation: https://www.rpmj.ru/rpmj/article/view/550/369; Степанова Ю.А., Калинин Д.В., Вишневский В.А. Первичномножественные опухоли (обзор литературы). Медицинская Визуализация. 2015; (6): 93–102.; Ying X, Zhang H, Chen B, Wu H, Bao L, Qian S, et al. Multiple metachronous rare primary malignant tumors: A case report. Thorac Cancer. 2019 Oct; 10(10): 2050–2053. https://doi.org/10.1111/1759–7714.13182; Bray F Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018; 68(6): 394–424. https://doi.org/10.3322/caac.21492; Popoola AA, Abiola OO, Buhari T, Ushie AF, Olanipekun HB, Arogundade AK. Multiple primary cancers: Simultaneously occurring prostate cancer and other primary tumors-our experience and literature search. Niger J Clin Pract. 2017; 20(3): 278–282. https://doi.org/10.4103/1119–3077.187331; Frank C, Sundquist J, Hemminki A, Hemminki K. Familial Associations Between Prostate Cancer and Other Cancers. Eur Urol. 2017; 71(2): 162–165. https://doi.org/10.1016/j.eururo.2016.07.031; Клинические рекомендации саркомы мягких тканей. Ассоциация онкологов России, Восточно-Европейская группа по изучению сарком. 2016.; Близнюков О.П. Плеоморфные саркомы: морфология, молекулярно-биологические и клинические свойства. Автореферат, дисс… доктор медицинских наук, М., 2013.; Key Statistics for Soft Tissue Sarcomas [Internet]. Доступно по: https://www.cancer.org/cancer/soft-tissue-sarcoma/about/key-statistics.html. Дата обращения: 21.01.2020.; Lu L, Shi HZ, Xiao ZJ, Wang D, Li CL. Clinical experience in diagnosis and treatment of primary retroperitoneal liposarcoma. Zhonghua Yi Xue Za Zhi. 2018 Mar 13; 98(10): 773–776. https://doi.org/10.3760/cma.j.issn.0376–2491.2018.10.012; Fernández-Ruiz M, Rodríguez-Gil Y, Guerra-Vales JM, Manrique-Municio A, Moreno-González E, Colina-Ruizdelgado F. Primary retroperitoneal liposarcoma: clinical and histological analysis of ten cases. Gastroenterol Hepatol. 2010 May; 33(5): 370–376. https://doi.org/10.1016/j.gastrohep.2009.12.010; Chiappa A, Bertani E, Pravettoni G, Zbar AP, Foschi D, Spinoglio G, et al. Aggressive Surgical Approach for Treatment of Primary and Recurrent Retroperitoneal Soft Tissue Sarcoma. Indian J Surg. 2018 Apr; 80(2): 154–162. https://doi.org/10.1007/s12262–018–1722–7; https://www.rpmj.ru/rpmj/article/view/550